Home
Categories
Ingredients
Analysis
Manufacturing
Finance
Regulatory
Drug Delivery
Research & Development
Sustainability
Pharma 5.0
Company News
Events
Directory
Search
Close search
Home
Company
Bio N Tech
Bio N Tech
X
LinkedIn
Trending Articles
Agilent boosts contract manufacturing capabilities with acquisition of BIOVECTRA
The CDMO acquisition will bolster Agilent's end-to-end production capabilities in a number of popular therapeutics, including GLP-1 medications and ADCs
KBI Biopharma extends contract with a big pharma giant after a successful FDA inspection
The contract has been renewed and extended until at least 2029, and will now include the purchase of two therapeutic products
Currax to build novel anti-obesity treatment production facility amidst GLP-1 supply issues
The manufacturing facility will be dedicated to the production of anti-obesity drug Contrave, and will double its output in the EU and EEA
New FAIRY viral assay could 'revolutionise' the response to future pandemics
The assay, which can detect the infectiousness of a virus in a matter of minutes, offers a quicker and cheaper alternative to the standard cell culture approach
New advice from BOLA and Labtex on cleaning and handling of PTFE products after use
The companies share: "Abrasive scouring agents may result in a milkiness of the vessels made of PFA and FEP. You may use all neutral detergents (pH 7). For higher contamination...
Upcoming event
ISPE Singapore
28-30 August 2024 | Conference and exhibition | Singapore
See all
Related Content
Manufacturing
Eurofarma to manufacture Pfizer-BioNTech doses for Latin America
Annual production is planned to exceed 100 million COVID-19 vaccine doses annually and all of these will exclusively be distributed within Latin America
Manufacturing
Biovac to manufacture Pfizer-BioNTech vaccine for African Union
Pfizer and BioNTech expect the Cape Town facility to be incorporated into the vaccine supply chain by the end of 2021
Manufacturing
Takara Bio signs license and supply agreement with BioNTech
Under the agreement BioNTech is allowed to use RetroNectin for production of its cell & gene therapy products
Manufacturing
Evonik delivers first lipids from German facility to BioNTech
The lipids are used for Pfizer and BioNTech's COVID-19 vaccine, as part of a lipid nanoparticle
Finance
Report details relative uptake of COVID-19 vaccines in EU
$746 m worth of the vaccines have been distributed in the EU with Pfizer taking 67% market share
Packaging
Softbox supports Pfizer in COVID-19 vaccine distribution
When correctly managed, the company says, the ULT Shipper can be used to store vaccines for in excess of 30 days
Manufacturing
AMRI provides excipient manufacturing services for Pfizer-BioNTech
The company has been chosen as part of a network of manufacturers to support the vaccine's continued supply
Subscribe now